Back to search

Article

An engineered serum albumin-binding AAV9 capsid achieves improved liver transduction after intravenous delivery in mice

2019-07-08

Abstract excerpt

<h4>ABSTRACT</h4> Recombinant adeno-associated viral (AAV) vectors are frequently used to deliver nucleic acids for in vivo applications and are currently the leading platform for therapeutic gene delivery in gene therapy clinical trials. Presently, there is a need for improved AAV vectors with optimized transduction efficiency in target tissues. In these studies, an engineered albumin-binding consensus domain (A...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8e37b823-9346-5905-9fef-645927ba3783
DOI
10.1101/694513
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An engineered serum albumin-binding AAV9 capsid achieves improved liver transduction after intravenous delivery in miceDOI 10.1101/694513
Select a neighboring publication to make it the new centre.